Emitech is now testing the radiated immunity of medical devices above 6 GHz, a frequency range that is not covered by current standards. The French testing and certification group is moving to fill a regulatory gap that has become increasingly relevant as medical equipment incorporates 5G and Wi‑Fi 6E/7 connectivity.
The goal is to anticipate the expectations of the U.S. Food and Drug Administration (FDA) and help customers secure the launch of their medical devices on the American market. By extending electromagnetic compatibility (EMC) testing into this higher-frequency band, Emitech aims to support manufacturers facing a standards landscape that has not yet fully caught up with the latest wireless technologies.
The move positions Emitech as a preparatory partner for companies developing connected medical equipment, especially those that need to demonstrate robustness against interference in environments where 5G and next-generation Wi‑Fi signals are present.